**How to Choose Blood Collection Supplies for Mobile Phlebotomy in the U.S.**

Summary

• Mobile phlebotomists should evaluate supplies for specimen quality, patient safety, portability, regulatory compliance, and compatibility with the receiving laboratory.
• Total purchasing cost includes product price, shipping, storage, waste disposal, expiration losses, recollection costs, and the operational time required to manage supplies.
• A risk-based purchasing system should combine approved product specifications, lot tracking, inventory controls, vendor evaluation, and documented quality procedures.

Mobile Phlebotomy has become an important part of healthcare delivery in the United States. Instead of requiring every patient to travel to a hospital, physician office, laboratory draw station, or outpatient center, mobile phlebotomists collect specimens in homes, workplaces, assisted-living facilities, skilled-nursing facilities, and other community settings. This model can improve convenience and access, particularly for older adults, homebound patients, people with disabilities, and individuals receiving home healthcare.

However, purchasing supplies for mobile blood collection is more complex than selecting the lowest-priced tubes and needles. A mobile phlebotomist must carry a safe and practical collection system into changing environments while protecting patients, preserving Specimen Integrity, complying with federal and state requirements, and meeting the receiving laboratory’s exact specifications.

The stakes are significant. Laboratory medicine influences an estimated 70% of medical decisions, according to frequently cited industry and professional laboratory reports, even though laboratory services represent a relatively small share of total healthcare spending. A mislabeled tube, an inadequate volume, a hemolyzed specimen, or an improperly transported sample can delay diagnosis, require recollection, increase costs, and create an avoidable patient-safety risk.

For mobile professionals, the best purchasing decision is therefore not simply a product decision. It is a Workflow, quality, compliance, and logistics decision. The following factors can help U.S. mobile phlebotomists build a reliable blood collection supply program.

Start With the Testing Laboratory’s Requirements

The most important purchasing factor is compatibility with the laboratory that will receive and process the specimens. Blood collection tubes, needles, transfer devices, transport containers, preservatives, and handling methods are not universally interchangeable. Each laboratory may have its own approved manufacturers, tube types, minimum volumes, stability limits, order-of-draw procedures, and rejection criteria.

Before placing a large supply order, mobile phlebotomists should obtain written collection and transportation instructions from every laboratory they routinely use. A requisition may identify the requested test, but it does not always provide enough information about the correct specimen type. The laboratory’s test directory or collection manual should be treated as the controlling source.

Important questions include:

1. Which tube type and additive are required for each commonly ordered test?
2. What is the minimum acceptable volume for pediatric, geriatric, and adult specimens?
3. Are alternate tube sizes or manufacturers permitted?
4. Does the laboratory require serum, plasma, whole blood, or a specialized specimen?
5. What temperature and time limits apply during transportation?
6. Which specimens require protection from light, freezing, or excessive heat?
7. What labeling, centrifugation, mixing, and packaging procedures are required?
8. Which collection devices are not accepted because of additive differences, gel composition, or instrument validation?

Using an incorrect tube can produce inaccurate results even when the draw itself appears successful. For example, anticoagulant-to-blood ratios matter for coagulation testing, while additive carryover can affect chemistry, hematology, or Toxicology results. A tube that looks similar to an approved product may still be unsuitable for a particular analyzer or laboratory method.

Mobile phlebotomists should maintain a test-to-supply reference table that connects common laboratory orders with the required tube, draw volume, handling instructions, and transport conditions. This reduces guesswork during field visits and helps prevent the purchase of supplies that cannot be used by the receiving laboratory.

Evaluate Tube Types, Additives, and Specimen Quality

Blood collection tubes are among the most important supplies in a phlebotomy operation. The correct choice depends on the tests being ordered and the laboratory’s validated procedures.

Common tube categories

Serum tubes are commonly used for chemistry, serology, and some hormone testing. They may contain no additive, a Clot Activator, or a Separator Gel. Plasma tubes contain anticoagulants such as Heparin and may also include a gel barrier. Ethylenediaminetetraacetic acid, commonly called EDTA, is used for many hematology tests because it preserves cellular components. Sodium Citrate tubes are commonly used for coagulation testing and require careful attention to the blood-to-additive ratio.

Other specialized tubes may be required for blood cultures, trace-element testing, glucose preservation, molecular testing, Therapeutic Drug Monitoring, or specialized genetic and infectious-disease assays. A mobile phlebotomist should not assume that one “general-purpose” tube can serve multiple categories of tests.

Tube size and fill volume

Tube size affects patient comfort, specimen volume, additive ratios, storage space, and transport weight. Smaller tubes may be appropriate for pediatric or difficult draws, but only when the receiving laboratory permits them. Underfilling a tube can be particularly problematic for coagulation tests because the concentration of citrate is designed for a specific blood volume. Overfilling or underfilling may alter results or cause the laboratory to reject the specimen.

Purchasing decisions should account for the actual patient population. A mobile service focused on homebound older adults may need more small-volume tubes, butterfly sets, and pediatric options than a workplace screening service. A service supporting oncology, home infusion, or specialty testing may need a broader range of tubes and collection devices.

Hemolysis and Specimen Rejection

Hemolysis is one of the most common reasons for Specimen Rejection in many laboratory settings. Published laboratory quality studies often identify hemolysis as accounting for approximately 40% to 70% of rejected specimens, although the percentage varies by institution, specimen type, and reporting method. Hemolysis can result from difficult Venipuncture, excessive suction, forcing blood through a needle, vigorous tube shaking, alcohol that has not dried, or improper transportation.

Supply selection can influence this risk. Needle Gauge, butterfly tubing, tube vacuum strength, syringe-transfer methods, and tube design all affect collection. Mobile phlebotomists should ask laboratories whether they have observed higher rejection rates with particular devices. A low-cost product that increases recollection rates may be more expensive overall than a higher-priced product with better performance.

Select Needles and Collection Sets for the Patient Population

Needles and blood collection sets must be selected according to the patient, the test requirements, the phlebotomist’s technique, and the setting. Common options include straight needles, winged infusion sets, safety needles, syringe-based systems, and specialized devices for difficult access.

Safety-engineered devices are especially important in mobile work because the phlebotomist may be working in a bedroom, vehicle, workplace, or facility where the physical layout is less controlled than a dedicated laboratory draw station. The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers covered by the standard to use engineering and work-practice controls and to consider safer medical devices through an exposure-control process.

The Needlestick Safety and Prevention Act strengthened requirements for safer medical devices and employee input in applicable workplaces. The National Institute for Occupational Safety and Health has also emphasized the importance of eliminating unnecessary sharps exposure through safer devices, training, and disposal practices.

When comparing needles and sets, mobile phlebotomists should assess:

1. Needle Gauge and length options.
2. Availability of integrated safety mechanisms.
3. Ease of one-handed activation after Venipuncture.
4. Visibility of blood flashback.
5. Dead space and tubing volume.
6. Compatibility with evacuated tube systems and syringes.
7. Performance with fragile, small, or Difficult Veins.
8. Packaging size and protection from damage during transport.
9. Training Requirements for each device.
10. Availability of replacement stock during supplier shortages.

A 21-gauge needle is often used for routine adult Venipuncture, while smaller gauges may be selected for certain patients or circumstances. Nevertheless, gauge selection should be based on clinical judgment and laboratory compatibility rather than a rigid rule. A device that is too small or used with excessive force may increase hemolysis, prolong collection, or cause clotting in the tubing.

Butterfly sets can be useful for shallow, fragile, or Difficult Veins, but they often involve tubing dead space and may require a discard tube or another validated technique for coagulation specimens. The receiving laboratory should provide instructions for these situations. Mobile purchasers should also confirm whether each safety device is compatible with their staff’s training and whether it can be activated reliably in the field.

Prioritize Patient Safety and Infection Prevention

Mobile Phlebotomy does not reduce infection-control responsibilities. It can increase them because the collection environment changes from visit to visit. Supplies must support standard precautions, Hand Hygiene, skin antisepsis, environmental cleaning, and safe disposal.

Essential infection-prevention supplies may include alcohol-based hand sanitizer, hand soap access when available, gloves in multiple sizes, skin antiseptic products, disinfectant wipes, clean barriers, bandages, gauze, tourniquets, and leak-resistant specimen bags. Depending on the patient population and setting, the phlebotomist may also need masks, eye protection, gowns, or other personal protective equipment.

Gloves should fit properly. A glove that is too tight can cause hand fatigue and tearing, while a glove that is too loose may interfere with dexterity. Some patients and healthcare workers have latex sensitivity, so purchasing nitrile or other suitable latex-free options may reduce risk. The chosen glove should be appropriate for the task and should not be treated as a substitute for Hand Hygiene.

Skin antiseptic selection should follow laboratory, employer, and clinical policies. The antiseptic must be allowed to dry fully before puncture. Mobile purchasers should consider individual allergies, age-related skin fragility, and the types of procedures performed. Single-use products can improve portability and reduce contamination risk, although packaging and cost should be evaluated.

Tourniquets deserve particular attention. Reusable tourniquets can become contaminated if they are not cleaned and disinfected according to the manufacturer’s instructions. Single-patient or disposable tourniquets may be preferable in some home-care and infection-control programs. If reusable tourniquets are used, mobile phlebotomists need a clear process for segregating used items and cleaning them between patients.

Use Proper Sharps and Biohazard Waste Systems

Sharps disposal is a central purchasing issue for mobile phlebotomists. A portable operation must have an approved sharps container available at the point of use, not merely in the vehicle. The container should be closable, puncture resistant, leak resistant on the sides and bottom, labeled or color-coded as required, and maintained upright during transport and use.

The container size should match the daily workload and the service area. A container that is too small may fill during a route, while an oversized container may be difficult to secure in a mobile bag. The phlebotomist should never force a needle or other sharp into an overfilled container. OSHA commonly describes a fill line or an approach to approximately three-quarters full as a signal for closure and replacement, but the exact procedure should follow the container instructions and the organization’s exposure-control plan.

Sharps containers should not be placed loose in a car or carried in a soft bag without stabilization. They should remain upright, protected from crushing, and separated from clean supplies. A mobile service should also identify a legally compliant disposal vendor or waste-management process before beginning operations. Rules can vary by state and local jurisdiction, and some states impose specific requirements for medical waste transport, storage, labeling, and disposal.

Other regulated medical waste, such as blood-contaminated gauze or collection materials, must be handled according to applicable federal, state, local, facility, and contractual requirements. The U.S. Department of Transportation may regulate the transport of certain patient specimens and materials, while state environmental and health agencies may regulate waste streams. Purchasers should not assume that ordinary household trash procedures are acceptable.

Consider Packaging, Transport, and Temperature Control

Specimen transport is often the greatest operational challenge in Mobile Phlebotomy. A high-quality specimen can become unusable if it is exposed to incorrect temperature, excessive vibration, sunlight, leakage, or delays.

Packaging should protect both the specimen and people who handle it. For many routine patient specimens, a leak-resistant primary container is placed inside a leak-resistant secondary bag with absorbent material, and paperwork is kept in a separate outer compartment. The specific packaging arrangement depends on the specimen type, the carrier, and applicable transportation rules.

When specimens are shipped or transported through commercial carriers, the requirements may involve packaging standards and classification rules. For example, some specimens may qualify as exempt human specimens, while others may require more stringent packaging because of suspected infectious agents or the nature of the material. A Mobile Phlebotomy business should obtain written guidance from its laboratory and shipping provider rather than making assumptions based on the appearance of the sample.

Temperature monitoring

Many specimens must remain within a defined temperature range. “Room temperature” may be interpreted differently depending on the laboratory’s procedure, while refrigerated and frozen specimens require controlled handling. A vehicle trunk exposed to summer heat can quickly exceed acceptable limits. In the United States, outdoor and vehicle temperatures can vary dramatically, with some regions experiencing summer temperatures above 100 degrees Fahrenheit and winter conditions below freezing.

Mobile phlebotomists should evaluate insulated transport bags, cold packs, frozen packs, dry ice where permitted, temperature indicators, and data loggers. Cold packs should not directly contact specimens unless the laboratory has approved that arrangement, because localized freezing can damage some samples. Specimens should also be protected from unnecessary light when required.

A practical transport system may include separate compartments for ambient, refrigerated, and frozen materials. It should be easy to clean and should not allow specimens to roll, tip, or remain in direct contact with contaminated surfaces. If the service operates across long distances, temperature monitoring becomes more important than simply using an insulated bag.

Confirm Labeling and Patient Identification Supplies

Patient identification and specimen labeling errors are among the most serious preventable risks in blood collection. The Joint Commission has consistently identified patient identification as a major safety priority across healthcare. A mobile phlebotomist should use at least two patient identifiers according to the laboratory, facility, and employer policy.

Labels should generally be applied immediately after collection and in the presence of the patient, unless a specific validated Workflow says otherwise. Prelabeling tubes away from the patient creates an avoidable risk of specimen misidentification. Supplies should support clear documentation of the patient’s name or approved identifier, date of birth or another second identifier, collection date and time, collector identification, and any other information required by the laboratory.

Purchasing considerations include thermal label performance, adhesive quality, readability, barcode compatibility, resistance to condensation, and suitability for refrigerated transport. Handwritten labels may be acceptable in certain circumstances, but they must be legible and complete. Labels that peel off in a cold bag or become unreadable after exposure to moisture create quality and tracking problems.

Mobile phlebotomists should also consider printers, backup labels, permanent markers approved for laboratory use, requisition forms, specimen logs, and tamper-evident materials where required. Any electronic system used for registration or labeling should have appropriate access controls and privacy safeguards.

Protect Privacy and Secure Documentation

Specimen collection involves protected health information. The Health Insurance Portability and Accountability Act, or HIPAA, applies to covered entities and business associates, and Mobile Phlebotomy companies may have obligations depending on their relationships with laboratories, providers, insurers, and patients.

Supply purchasing should therefore include secure document storage and transport. Paper requisitions should not be left visible in a vehicle, and specimen bags should not expose patient information unnecessarily. Mobile devices used for registration or labeling should have passwords, automatic locking, encryption where appropriate, and procedures for lost or stolen equipment.

Printed materials should be stored in a way that protects confidentiality during home visits and transportation. If a mobile phlebotomist uses a courier, the chain of custody should identify when the specimen was released, who received it, and whether the package was intact. These practices support both patient privacy and specimen traceability.

Assess Product Quality, Certification, and Regulatory Status

Not every product marketed for blood collection is equivalent. Before purchasing, mobile phlebotomists should verify that products are intended for clinical use in the United States, are supplied in intact manufacturer packaging, and include lot numbers, expiration dates, storage instructions, and clear instructions for use.

The U.S. Food and Drug Administration regulates many medical devices used for blood collection. The regulatory pathway may differ by product type, and a device’s legal marketing status should be confirmed through appropriate manufacturer documentation and FDA resources when necessary. FDA clearance or authorization does not replace the need to verify laboratory compatibility or user performance.

Purchasers should inspect products for:

1. Intact sterile packaging.
2. Expiration dates that allow adequate time for use.
3. Lot or batch numbers for traceability.
4. Clear manufacturer instructions.
5. Storage conditions that can be met during mobile operations.
6. Consistent labeling and packaging across shipments.
7. Evidence of damage, contamination, leakage, or temperature exposure.
8. Documentation of recalls or safety notices.

Expiration management is particularly important for mobile services that order in bulk. A discount is not a savings if products expire before use. The first-expire, first-out method can reduce waste. Some supplies, including tubes, reagents, antiseptics, and test-specific collection devices, may have relatively short usable lives or storage restrictions.

Manufacturers and distributors should be able to provide certificates, product specifications, safety information, and recall notifications when appropriate. A reputable supplier should also explain whether products are genuine manufacturer items, private-label products, or compatible alternatives.

Calculate Total Cost Rather Than Unit Price

Unit price is only one part of the purchasing decision. The total cost of a supply includes shipping, minimum-order requirements, storage, expired inventory, waste disposal, training, equipment maintenance, and the consequences of failed collections.

For example, a lower-priced needle may appear attractive, but the calculation changes if it produces more patient discomfort, increases hemolysis, requires more recollections, or takes longer to use safely. Similarly, a cheaper transport bag may not be economical if it cannot maintain temperature or must be replaced frequently.

A useful purchasing analysis can include:

1. Price per usable item rather than price per package.
2. Freight, fuel surcharges, and delivery fees.
3. Minimum order quantities and storage requirements.
4. Expected expiration and spoilage losses.
5. Recollection costs and staff travel time.
6. Specimen Rejection rates associated with the product.
7. Training and implementation costs.
8. Waste disposal fees.
9. Costs related to recalls, shortages, or emergency purchases.
10. Payment terms and contract obligations.

Mobile phlebotomists can estimate the financial effect of recollection by combining the cost of new supplies, additional travel, labor time, delayed billing, patient inconvenience, and possible lost referrals. Even a modest reduction in rejected specimens may justify a higher purchase price when the service covers a large geographic area.

Build an Inventory System for Mobile Operations

Inventory control is more difficult when supplies are divided among a central storage location, vehicles, mobile bags, and temporary field sites. Without a system, supplies may be overstocked in one location and unavailable in another.

Each mobile kit should contain a standardized minimum stock level. The kit should be checked before the first appointment of the day and restocked after the route. A central inventory log should record quantities, lot numbers, expiration dates, and storage locations for supplies that require traceability.

Mobile services should establish reorder points based on average use, peak demand, supplier lead time, and emergency reserve needs. The Covid-19 pandemic demonstrated how quickly healthcare supply chains can be disrupted. In response to shortages of gloves, masks, tubes, and other products, many healthcare organizations adopted dual sourcing, safety stock, substitution protocols, and more frequent inventory reviews.

A reasonable reserve depends on the product and the business model. High-volume, standard items may justify a larger reserve, while expensive or specialized items may be ordered more cautiously. Supplies with long lead times or limited manufacturers require earlier ordering than commonly available gloves or gauze.

Inventory should be protected from excessive heat, freezing, moisture, direct sunlight, dust, and unauthorized access. A vehicle is not automatically an appropriate storage area. Temperature-sensitive items should be removed from vehicles after routes unless the vehicle has validated environmental controls.

Evaluate Suppliers and Distribution Reliability

A supplier should be evaluated on more than catalog size. Delivery reliability, product authenticity, customer support, recall communication, back-order management, and return policies are all important for Mobile Phlebotomy.

Purchasers should ask whether the supplier:

1. Maintains consistent access to the specific products used by the receiving laboratory.
2. Provides advance notice of back orders and substitutions.
3. Offers lot and expiration information before shipment when requested.
4. Has a clear process for damaged or incorrect deliveries.
5. Communicates manufacturer recalls quickly.
6. Can support recurring orders and emergency replenishment.
7. Provides invoices suitable for accounting and Reimbursement records.
8. Has customer service staff who understand clinical supply specifications.
9. Can document product origin and authenticity.
10. Offers reasonable shipping options to the service’s geographic area.

It is often wise to approve at least one backup supplier for essential products. However, switching brands without laboratory approval can create problems. A backup plan should identify which substitutions are already accepted and which require review before use.

Account for State Laws and Professional Scope

Phlebotomy regulation in the United States is not completely uniform. Federal requirements may apply to workplace safety, laboratory testing, privacy, transportation, and medical waste, while states may impose additional requirements for phlebotomy practice, laboratory personnel, business licensing, home healthcare, bloodborne pathogens, and waste disposal.

California, Louisiana, Nevada, and Washington are examples of states with notable personnel certification or licensing requirements for some laboratory and phlebotomy roles, although the details and exemptions differ. Other states may regulate the employer, laboratory, or healthcare facility rather than requiring a standalone phlebotomy license. Requirements can also vary based on whether the individual is an employee, independent contractor, clinical laboratory personnel member, home-health worker, or part of a physician practice.

Before purchasing or advertising services, a mobile phlebotomist should confirm the rules applicable to the state and local jurisdictions in which services are provided. The business should also determine whether it operates under a laboratory’s Clinical Laboratory Improvement Amendments, or CLIA, framework, whether it performs any testing on site, and whether a certificate or additional quality procedures are required.

The Centers for Medicare and Medicaid Services administers CLIA requirements for applicable laboratory testing. A person who only collects specimens and sends them to a qualified laboratory may have different obligations from an organization that performs waived, moderate-complexity, or High-Complexity testing. The distinction should be clarified before purchasing analyzers, point-of-care kits, or testing supplies.

Use Standardized Quality-Control Procedures

A Mobile Phlebotomy supply program should be supported by written procedures. Standardization reduces variation among collectors and makes training easier. Procedures should cover patient identification, order verification, Hand Hygiene, site selection, Tourniquet use, order of draw, tube mixing, labeling, packaging, transport, incident reporting, and supply inspection.

The Clinical and Laboratory Standards Institute publishes widely used guidance for venous blood collection and specimen handling. While organizations must follow the requirements of their employer, laboratory, and applicable regulators, CLSI-based procedures can provide a useful framework for standardization.

Quality indicators may include:

1. Specimen Rejection rate.
2. Hemolysis rate.
3. Clotted specimen rate.
4. Quantity-not-sufficient rate.
5. Mislabeling or identification incidents.
6. Percentage of specimens delivered within the required time.
7. Temperature excursions during transport.
8. Sharps injuries and near misses.
9. Expired or discarded supply value.
10. Patient complaints related to collection devices or procedures.

Tracking these measures helps determine whether a product change improves performance. If a new tube or needle is introduced, the mobile service should compare rejection and incident data before and after implementation. Feedback from the receiving laboratory is especially valuable because the laboratory can identify problems that may not be visible during the home visit.

Plan for Special Populations and Challenging Environments

Mobile phlebotomists frequently serve patients who require more preparation than a standard outpatient draw. Older adults may have fragile veins, thin skin, dehydration, or limited mobility. Pediatric patients may need small-volume collection devices and age-appropriate comfort measures. Patients receiving chemotherapy, dialysis, Infusion Therapy, or anticoagulants may have additional restrictions or collection considerations.

Supplies should be selected with the patient population in mind, but clinical decisions must remain within the phlebotomist’s training and scope. For example, a patient with an arteriovenous fistula, mastectomy history, central venous access device, or significant bleeding risk may require specific instructions from the ordering provider or laboratory.

The environment also matters. A home may have limited lighting, pets, clutter, poor seating, or no convenient handwashing sink. A workplace may involve privacy concerns and time pressure. An assisted-living facility may require coordination with nursing staff and multiple patient collections. Mobile supply bags should include clean barriers, adequate lighting options, Hand Hygiene supplies, and a reliable way to keep clean and used materials separate.

Make Purchasing Decisions Through a Formal Process

Even a small Mobile Phlebotomy business benefits from a formal purchasing process. The process does not need to be complicated, but it should document why a product was selected and how it will be monitored.

A practical approach includes the following steps:

1. List the tests and patient populations served.
2. Obtain current collection requirements from each receiving laboratory.
3. Define specifications for tubes, needles, safety devices, labels, packaging, and transport equipment.
4. Compare at least two suitable products when practical.
5. Request samples for supervised evaluation before committing to large quantities.
6. Confirm regulatory, storage, expiration, and disposal requirements.
7. Calculate total cost, including labor and recollection risk.
8. Approve the product through the responsible clinician, laboratory, or quality manager.
9. Train all collectors on the selected product and document competency where required.
10. Monitor quality indicators and review the supplier periodically.

Product trials should be structured rather than based only on personal preference. The evaluation can measure ease of use, patient comfort, collection time, tube fill, hemolysis, leakage, labeling durability, and laboratory acceptance. A product that performs well in a controlled clinic may behave differently in a mobile setting, so field testing is important.

Conclusion

Purchasing blood collection supplies for Mobile Phlebotomy in the United States requires a balance of clinical performance, patient safety, regulatory compliance, logistics, and cost control. The most reliable supply program begins with the receiving laboratory’s requirements and then builds outward to include appropriate tubes, safety-engineered needles, infection-prevention products, sharps containers, secure labels, transport packaging, temperature controls, and inventory procedures.

Mobile phlebotomists should also consider the realities of the populations and environments they serve. Fragile veins, long travel distances, changing temperatures, limited workspace, privacy concerns, and supplier shortages all affect which products are practical. A documented quality system makes it easier to identify problems, compare vendors, manage recalls, and prevent avoidable recollections.

The lowest purchase price is rarely the same as the lowest total cost. The strongest purchasing decisions are those that consistently produce acceptable specimens, protect patients and workers, meet laboratory requirements, and remain dependable across the full mobile Workflow—from the supply room to the patient’s home and finally to the testing laboratory.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos